Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The ICN was launched to forge a predictable regulatory path for evaluating the safety and efficacy of therapies for neonates. At the May INC Annual Workshop in Bethesda, Maryland, we will discuss “Endpoints for Evaluating Pain Treatments for Neonates”.